ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities

November 22, 2024

  • Vendor-agnostic, multi-modality Radiology Operations Command Center (ROCC) connects technologists, radiologists, and operations teams in real time
  • New FDA 510(k) cleared remote scanning and protocol management help improve the operation of radiology workflows

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major step forward in making radiology expertise for  diagnostic imaging accessible to more patients. The U.S. Food and Drug Administration (FDA) 510(k) clearance of remote scanning and remote protocol adjustment features on Philips Radiology Operations Command Center (ROCC) [1] means expert radiologists can now assist technologists on-the-spot, by remotely controlling scans or adjusting protocols to acquire high quality images needed for improved diagnostic confidence and patient outcomes.

“With the ROCC, innovation takes the lead in revolutionizing our daily radiology operations, enhancing our imaging capabilities, and providing staffing flexibility, enabling us to ultimately serve more patients more efficiently, overall delivering better patient care,” said Sherri Lewman, senior vice president of Enterprise Imaging at Tampa General Hospital [2].

ROCC is a multi-vendor, multi-modality, safe and secure imaging solution widely used in North America and Europe. It can be used with any vendor MR or CT configuration and seamlessly connects imaging experts in a command center with technologists at scan locations across their organization. A pilot study at Imperial College Healthcare NHS Trust in London, UK resulted in a 9% increase in total scanning throughput as a result of reduced scan times and a zero exam recall rate over the study period [3].

The remote scanning capabilities of ROCC [1] allow expert users to edit MR and CT scanner consoles in real time, from any location and share their expertise via on-demand chat, voice and video collaboration, without compromising privacy, safety or security. ROCC enables remote collaboration between imaging experts and on-site technologists to help with precise, first-time right image acquisition, for more efficient and enhanced patient care. 

“Healthcare providers are increasingly confronted with the challenge of not having enough skilled technologists to meet the demand for patient imaging exams, particularly for more complex exams such as cardiac MR,” said Shiv Gopalkrishnan, Business Leader Patient Care Informatics at Philips. “With the 510(k) clearance of ROCC’s remote scanning and remote protocol management capabilities [1] we are further empowering clinicians to deliver the timely diagnosis that patients deserve and helping to deliver better care for more patients.”

Philips will showcase ROCC in the Philips booth (#6730) at the Radiological Society of North America Annual Meeting, Dec. 1-4, 2024, in Chicago, USA. For more information, visit Philips at RSNA 2024.

[1] Remote editing and protocol management are functions powered by the 510(k) cleared ROCC Console solution. Remote Image Acquisition is only to be used with a qualified user at the scanner.
[2] TGH Imaging Implements Philips Radiology Operations Command Center (ROCC) | Tampa General Hospital
[3] Based on results achieved in the ROCC Connectivity-Imperial NHS Trust Pilot Study. Increasing Imperial-NHS cardiac scanning capacity using ROCC for virtual training white paper. September 2024. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.

For further information, please contact:

Anna Hogrebe
Philips Global Press Office
Tel.: +1 416 270 6757
E-mail: anna.hogrebe@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.25
+2.28 (1.00%)
AAPL  269.00
+0.19 (0.07%)
AMD  258.01
-1.66 (-0.64%)
BAC  52.87
-0.15 (-0.28%)
GOOG  268.43
-1.50 (-0.56%)
META  751.44
+0.62 (0.08%)
MSFT  542.07
+10.55 (1.98%)
NVDA  201.03
+9.54 (4.98%)
ORCL  280.83
-0.57 (-0.20%)
TSLA  460.55
+8.13 (1.80%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.